Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Melanoma 1Medulloblastoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1Brain Neoplasms 1Basal Cell Nevus Syndrome 1

Interventions

sonidegib 4HhAntag691 4gusacitinib 3IPI-926 3tazarotene 2Photochemotherapy 2Drug Evaluation 2Aminolevulinic Acid 21-phenyl-3,3-dimethyltriazene 2merphos 1Watchful Waiting 1Vincristine 1Solutions 1Sirolimus 1Red Light 1Nivolumab 1NVP-BKM120 1Microarray Analysis 1Methotrexate 1Mental Status and Dementia Tests 1Mass Spectrometry 1Ipilimumab 1Gene Expression Profiling 1Fluorouracil 1Etoposide 1Cyclophosphamide 1Comparative Genomic Hybridization 1Carnitine 1Carboplatin 1Blue Light 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Basal Cell Nevus Syndrome × Mental Status and Dementia Tests × Dermatologic × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡